Oxford BioMedica (OXBDF) Receives a Buy from Canaccord Genuity
In a report released yesterday, from Canaccord Genuity reiterated a Buy rating on Oxford BioMedica, with a price target of p451.00. The company’s shares closed yesterday at $8.41.Elevate Your Investing...
RBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)
RBC Capital analyst Charles Weston reiterated a Buy rating on Oxford BioMedica today and set a price target of p970.00. The company’s shares closed last Wednesday at $7.91.Elevate Your Investing Strategy:...